Nautilus Biotechnology, Inc.NAUTNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-64.43M
↓ 224% below average
Average (6y)
$51.86M
Historical baseline
Range
High:$626.60M
Low:$-74.30M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-64.43M | +13.3% |
| 2023 | $-74.30M | -36.3% |
| 2022 | $-54.51M | -14.8% |
| 2021 | $-47.47M | -257.7% |
| 2020 | $-13.27M | -38.8% |
| 2019 | $-9.56M | -101.5% |
| 2018 | $626.60M | - |